Founder of the Academic Health Economists' Blog. Senior Principal Economist at the Office of Health Economics. ORCID: 0000-0001-9470-2369
The UK government is reportedly preparing to raise NICE’s cost-effectiveness threshold by 25%, as a bargaining chip to avoid US pharmaceutical tariffs. It’s time for health economists to reclaim this space and defend evidence-based decision-making.
Chris Sampson challenges a recent article in The Lancet claiming that NICE recommendations reduce population health.
Chris shares his review of the summer 2024 HESG meeting at the University of Warwick, which was brimming with discussion of economic evaluation, career pathways, and the general election.
With a programme of research challenging current approaches to health state measurement and valuation, and all things EQ-5D, Chris provides his take on the latest EuroQol meeting.
Chris reviews the latest issue of AHEHP, with papers on digital health, screening, cost-effectiveness thresholds, and decision modelling.
Chris explains why he has quit his editorial roles and will no longer provide pre-publication peer reviews for academic journals.
Chris summarises his (not so) recent trip to Boston for the latest ISPOR Annual conference, with some commentary on digital health and open-source modelling.
Chris summarises the latest issue of AHEHP, which is full of novel topics and methods. Highlights include a new resource use measure and several reviews on cost-effectiveness and HTA.
Chris summarises the latest issue of EJHE, with a focus on papers relating to the EQ-5D and a review of unemployment and health care use.
Chris provides a report on the recent EuroQol Academy meeting, with the theme ‘From cradle to grave: can we measure and value HRQoL consistently over the lifespan?’